Matthew Gross will conclude his tenure as Chief Executive Officer of the Fisher-Titus Health system effective March 1, according to Dennis Doughty, chairman of the Fisher-Titus Health Board of Directors.
While serving as board chairman, Gross was appointed to the CEO role in December 2017 to ensure a stable changeover to new leadership following Lorna Stayer’s retirement as the health system’s top executive. He resigned his chairman position to work full time as CEO.
“As CEO, Matt has provided valuable leadership during this period of transition,” said Doughty. “Over the last 15 months, he has initiated organizational changes and implemented the fiscal business disciplines that have positioned Fisher-Titus to remain a successful independent community health system well into the future.
Replacing Gross will be Brent W. Burkey, MD who was named president of Fisher-Titus Medical Center in March 2018, and will now assume leadership as President/CEO of Fisher-Titus Health, according to Doughty. Prior to joining Fisher-Titus, Dr. Burkey held numerous leadership positions across a variety of disciplines including clinical, information technology, and operations during his 14-year tenure with Cleveland Clinic.
“I leave my duties in the very capable hands of Dr. Burkey who will now serve in the combined role of President/CEO for our health system,” said Gross. “Brent has spent the past 11 months working with our clinical and medical staff while at the same time developing a keen understanding of our community’s health-care needs and helping to establish our strategic direction for the future.”
Gross’s decision came with mixed emotions. “While I am looking forward to getting ‘back to my retirement’, I will very much miss the interaction with the 1200-plus employees and medical staff that make Fisher-Titus the special place that it is.”